Mozambique

Mozambique

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
8.03 (6.64 - 9.40) 2019 Modelled IHME
8.12 (6.83 - 9.52) 2018 Modelled IHME
8.33 (6.97 - 9.82) 2017 Modelled IHME
8.79 (7.36 - 10.35) 2016 Modelled IHME
9.34 (7.72 - 11) 2015 Modelled IHME
9.71 (8.01 - 11.44) 2014 Modelled IHME
10.04 (8.32 - 11.88) 2013 Modelled IHME
10.34 (8.55 - 12.29) 2012 Modelled IHME
10.64 (8.73 - 12.66) 2011 Modelled IHME
10.98 (8.97 - 13.09) 2010 Modelled IHME
11.36 (9.32 - 13.55) 2009 Modelled IHME
11.76 (9.63 - 13.92) 2008 Modelled IHME
12.17 (9.98 - 14.37) 2007 Modelled IHME
12.59 (10.31 - 14.85) 2006 Modelled IHME
13 (10.51 - 15.30) 2005 Modelled IHME
13.44 (10.89 - 15.86) 2004 Modelled IHME
13.92 (11.37 - 16.39) 2003 Modelled IHME
14.39 (11.79 - 16.98) 2002 Modelled IHME
14.78 (12.05 - 17.47) 2001 Modelled IHME
15.06 (12.27 - 17.93) 2000 Modelled IHME
15.27 (12.48 - 18.03) 1999 Modelled IHME
15.45 (12.66 - 18.23) 1998 Modelled IHME
15.6 (12.79 - 18.42) 1997 Modelled IHME
15.71 (12.86 - 18.54) 1996 Modelled IHME
15.75 (12.84 - 18.70) 1995 Modelled IHME
15.72 (12.86 - 18.50) 1994 Modelled IHME
15.66 (12.76 - 18.34) 1993 Modelled IHME
15.54 (12.67 - 18.27) 1992 Modelled IHME
15.38 (12.54 - 18.15) 1991 Modelled IHME
15.17 (12.29 - 17.90) 1990 Modelled IHME
7.24 (5.20 - 9.78) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.85 (0.62 - 1.09) 2019 Modelled IHME
0.86 (0.63 - 1.10) 2018 Modelled IHME
0.89 (0.64 - 1.16) 2017 Modelled IHME
1.27 (0.95 - 1.64) 2016 Modelled IHME
1.79 (1.34 - 2.29) 2015 Modelled IHME
2.06 (1.54 - 2.63) 2014 Modelled IHME
2.28 (1.73 - 2.94) 2013 Modelled IHME
2.48 (1.86 - 3.21) 2012 Modelled IHME
2.64 (1.96 - 3.46) 2011 Modelled IHME
2.79 (2.06 - 3.66) 2010 Modelled IHME
2.9 (2.14 - 3.77) 2009 Modelled IHME
2.97 (2.21 - 3.87) 2008 Modelled IHME
3.04 (2.24 - 3.94) 2007 Modelled IHME
3.14 (2.32 - 4.07) 2006 Modelled IHME
3.3 (2.44 - 4.24) 2005 Modelled IHME
4.25 (3.14 - 5.48) 2004 Modelled IHME
6.27 (4.62 - 8.19) 2003 Modelled IHME
8.63 (6.32 - 11.25) 2002 Modelled IHME
10.62 (7.79 - 13.90) 2001 Modelled IHME
11.55 (8.44 - 15.19) 2000 Modelled IHME
11.69 (8.64 - 15.35) 1999 Modelled IHME
11.81 (8.80 - 15.40) 1998 Modelled IHME
11.89 (8.80 - 15.39) 1997 Modelled IHME
11.94 (8.84 - 15.62) 1996 Modelled IHME
11.96 (8.79 - 15.82) 1995 Modelled IHME
11.94 (8.82 - 15.58) 1994 Modelled IHME
11.87 (8.79 - 15.39) 1993 Modelled IHME
11.75 (8.75 - 15.28) 1992 Modelled IHME
11.6 (8.57 - 15.25) 1991 Modelled IHME
11.42 (8.36 - 15.12) 1990 Modelled IHME
3.67 (2.51 - 5.46) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.49 (1.55 - 3.68) 2019 Modelled IHME
2.53 (1.58 - 3.79) 2018 Modelled IHME
2.57 (1.61 - 3.90) 2017 Modelled IHME
2.59 (1.62 - 3.93) 2016 Modelled IHME
2.67 (1.70 - 3.97) 2015 Modelled IHME
2.84 (1.83 - 4.19) 2014 Modelled IHME
3.1 (2.04 - 4.52) 2013 Modelled IHME
3.4 (2.29 - 4.85) 2012 Modelled IHME
3.67 (2.49 - 5.11) 2011 Modelled IHME
3.88 (2.70 - 5.40) 2010 Modelled IHME
3.84 (2.71 - 5.30) 2009 Modelled IHME
3.82 (2.72 - 5.26) 2008 Modelled IHME
3.75 (2.66 - 5.18) 2007 Modelled IHME
3.73 (2.65 - 5.12) 2006 Modelled IHME
3.71 (2.63 - 5.12) 2005 Modelled IHME
3.71 (2.63 - 5.14) 2004 Modelled IHME
3.81 (2.68 - 5.30) 2003 Modelled IHME
4 (2.79 - 5.67) 2002 Modelled IHME
4.19 (2.86 - 6.08) 2001 Modelled IHME
4.39 (2.96 - 6.44) 2000 Modelled IHME
4.41 (2.92 - 6.47) 1999 Modelled IHME
4.4 (2.87 - 6.50) 1998 Modelled IHME
4.38 (2.81 - 6.54) 1997 Modelled IHME
4.36 (2.78 - 6.60) 1996 Modelled IHME
4.36 (2.76 - 6.62) 1995 Modelled IHME
4.44 (2.82 - 6.75) 1994 Modelled IHME
4.6 (2.87 - 6.93) 1993 Modelled IHME
4.69 (2.94 - 7.18) 1992 Modelled IHME
4.69 (2.92 - 7.11) 1991 Modelled IHME
4.66 (2.92 - 7.07) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
736 (458 - 1,086) 2019 Modelled IHME
725 (453 - 1,089) 2018 Modelled IHME
717 (450 - 1,090) 2017 Modelled IHME
703 (439 - 1,067) 2016 Modelled IHME
706 (449 - 1,048) 2015 Modelled IHME
729 (471 - 1,077) 2014 Modelled IHME
775 (510 - 1,129) 2013 Modelled IHME
826 (557 - 1,179) 2012 Modelled IHME
869 (589 - 1,208) 2011 Modelled IHME
892 (621 - 1,241) 2010 Modelled IHME
859 (607 - 1,185) 2009 Modelled IHME
830 (592 - 1,143) 2008 Modelled IHME
794 (562 - 1,094) 2007 Modelled IHME
767 (545 - 1,052) 2006 Modelled IHME
742 (526 - 1,025) 2005 Modelled IHME
723 (512 - 1,001) 2004 Modelled IHME
722 (509 - 1,005) 2003 Modelled IHME
739 (516 - 1,048) 2002 Modelled IHME
754 (515 - 1,094) 2001 Modelled IHME
770 (520 - 1,130) 2000 Modelled IHME
754 (500 - 1,107) 1999 Modelled IHME
736 (479 - 1,086) 1998 Modelled IHME
715 (459 - 1,067) 1997 Modelled IHME
695 (444 - 1,053) 1996 Modelled IHME
679 (429 - 1,030) 1995 Modelled IHME
664 (421 - 1,007) 1994 Modelled IHME
645 (403 - 973) 1993 Modelled IHME
623 (390 - 954) 1992 Modelled IHME
612 (382 - 928) 1991 Modelled IHME
609 (382 - 925) 1990 Modelled IHME
1,082 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
40 (31 - 49) 2019 Modelled IHME
40 (32 - 50) 2018 Modelled IHME
40 (32 - 49) 2017 Modelled IHME
40 (32 - 49) 2016 Modelled IHME
40 (32 - 49) 2015 Modelled IHME
40 (32 - 49) 2014 Modelled IHME
40 (33 - 50) 2013 Modelled IHME
41 (33 - 50) 2012 Modelled IHME
42 (34 - 51) 2011 Modelled IHME
41 (34 - 51) 2010 Modelled IHME
41 (34 - 50) 2009 Modelled IHME
41 (34 - 50) 2008 Modelled IHME
41 (33 - 50) 2007 Modelled IHME
41 (33 - 50) 2006 Modelled IHME
42 (34 - 51) 2005 Modelled IHME
42 (34 - 51) 2004 Modelled IHME
42 (34 - 51) 2003 Modelled IHME
42 (34 - 51) 2002 Modelled IHME
42 (34 - 51) 2001 Modelled IHME
42 (34 - 51) 2000 Modelled IHME
42 (34 - 51) 1999 Modelled IHME
42 (33 - 51) 1998 Modelled IHME
41 (33 - 51) 1997 Modelled IHME
41 (33 - 51) 1996 Modelled IHME
41 (32 - 51) 1995 Modelled IHME
41 (32 - 50) 1994 Modelled IHME
40 (31 - 50) 1993 Modelled IHME
40 (31 - 50) 1992 Modelled IHME
40 (31 - 50) 1991 Modelled IHME
39 (30 - 49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
80 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
80 2016 Survey/reported WHO/UNICEF
80 2015 Survey/reported WHO/UNICEF
79 2014 Survey/reported WHO/UNICEF
78 2013 Survey/reported WHO/UNICEF
76 2012 Survey/reported WHO/UNICEF
76 2011 Survey/reported WHO/UNICEF
74 2010 Survey/reported WHO/UNICEF
74 2009 Survey/reported WHO/UNICEF
75 2008 Survey/reported WHO/UNICEF
75 2007 Survey/reported WHO/UNICEF
75 2006 Survey/reported WHO/UNICEF
75 2005 Survey/reported WHO/UNICEF
76 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
76 2002 Survey/reported WHO/UNICEF
25 2001 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.47 (1.17 - 1.85) 2019 Modelled IHME
1.47 (1.18 - 1.83) 2018 Modelled IHME
1.46 (1.17 - 1.83) 2017 Modelled IHME
1.45 (1.16 - 1.80) 2016 Modelled IHME
1.44 (1.14 - 1.79) 2015 Modelled IHME
1.44 (1.15 - 1.80) 2014 Modelled IHME
1.44 (1.16 - 1.80) 2013 Modelled IHME
1.45 (1.16 - 1.80) 2012 Modelled IHME
1.45 (1.17 - 1.81) 2011 Modelled IHME
1.45 (1.17 - 1.80) 2010 Modelled IHME
1.45 (1.17 - 1.80) 2009 Modelled IHME
1.44 (1.16 - 1.77) 2008 Modelled IHME
1.43 (1.15 - 1.76) 2007 Modelled IHME
1.42 (1.14 - 1.74) 2006 Modelled IHME
1.42 (1.14 - 1.73) 2005 Modelled IHME
1.42 (1.14 - 1.73) 2004 Modelled IHME
1.42 (1.14 - 1.75) 2003 Modelled IHME
1.43 (1.15 - 1.76) 2002 Modelled IHME
1.43 (1.15 - 1.77) 2001 Modelled IHME
1.44 (1.15 - 1.79) 2000 Modelled IHME
1.44 (1.16 - 1.80) 1999 Modelled IHME
1.45 (1.17 - 1.81) 1998 Modelled IHME
1.47 (1.18 - 1.83) 1997 Modelled IHME
1.49 (1.19 - 1.86) 1996 Modelled IHME
1.5 (1.21 - 1.87) 1995 Modelled IHME
1.51 (1.22 - 1.89) 1994 Modelled IHME
1.52 (1.23 - 1.90) 1993 Modelled IHME
1.53 (1.24 - 1.92) 1992 Modelled IHME
1.55 (1.25 - 1.93) 1991 Modelled IHME
1.56 (1.25 - 1.95) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
67.1 (62.90 - 71.20) 2014 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.28 (1.99 - 4.92) 2019 Modelled IHME
3.34 (2.03 - 5.06) 2018 Modelled IHME
3.4 (2.06 - 5.14) 2017 Modelled IHME
3.41 (2.07 - 5.15) 2016 Modelled IHME
3.52 (2.20 - 5.19) 2015 Modelled IHME
3.62 (2.33 - 5.26) 2014 Modelled IHME
3.69 (2.45 - 5.26) 2013 Modelled IHME
3.75 (2.57 - 5.29) 2012 Modelled IHME
3.84 (2.72 - 5.29) 2011 Modelled IHME
4 (2.89 - 5.45) 2010 Modelled IHME
3.97 (2.93 - 5.35) 2009 Modelled IHME
3.97 (2.96 - 5.29) 2008 Modelled IHME
3.93 (2.91 - 5.22) 2007 Modelled IHME
3.93 (2.95 - 5.18) 2006 Modelled IHME
3.91 (2.92 - 5.13) 2005 Modelled IHME
3.87 (2.88 - 5.10) 2004 Modelled IHME
3.87 (2.86 - 5.08) 2003 Modelled IHME
3.91 (2.90 - 5.07) 2002 Modelled IHME
3.92 (2.91 - 5.10) 2001 Modelled IHME
4.02 (2.99 - 5.19) 2000 Modelled IHME
4.04 (3 - 5.21) 1999 Modelled IHME
4.04 (2.99 - 5.27) 1998 Modelled IHME
4.03 (2.96 - 5.27) 1997 Modelled IHME
4.02 (2.94 - 5.26) 1996 Modelled IHME
4.04 (2.95 - 5.28) 1995 Modelled IHME
4.13 (3 - 5.41) 1994 Modelled IHME
4.29 (3.14 - 5.65) 1993 Modelled IHME
4.39 (3.21 - 5.85) 1992 Modelled IHME
4.39 (3.21 - 5.89) 1991 Modelled IHME
4.36 (3.19 - 5.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
967 (587 - 1,451) 2019 Modelled IHME
958 (582 - 1,453) 2018 Modelled IHME
949 (576 - 1,435) 2017 Modelled IHME
925 (562 - 1,399) 2016 Modelled IHME
929 (580 - 1,370) 2015 Modelled IHME
930 (598 - 1,351) 2014 Modelled IHME
923 (612 - 1,314) 2013 Modelled IHME
911 (624 - 1,285) 2012 Modelled IHME
907 (643 - 1,251) 2011 Modelled IHME
919 (665 - 1,252) 2010 Modelled IHME
888 (654 - 1,196) 2009 Modelled IHME
863 (644 - 1,150) 2008 Modelled IHME
830 (616 - 1,103) 2007 Modelled IHME
807 (607 - 1,064) 2006 Modelled IHME
782 (584 - 1,027) 2005 Modelled IHME
754 (560 - 994) 2004 Modelled IHME
733 (543 - 963) 2003 Modelled IHME
723 (535 - 936) 2002 Modelled IHME
706 (524 - 917) 2001 Modelled IHME
705 (524 - 910) 2000 Modelled IHME
690 (514 - 891) 1999 Modelled IHME
675 (499 - 880) 1998 Modelled IHME
658 (484 - 859) 1997 Modelled IHME
641 (469 - 839) 1996 Modelled IHME
628 (458 - 821) 1995 Modelled IHME
616 (448 - 808) 1994 Modelled IHME
601 (440 - 792) 1993 Modelled IHME
583 (426 - 776) 1992 Modelled IHME
573 (419 - 769) 1991 Modelled IHME
570 (417 - 764) 1990 Modelled IHME
618 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
13 (9 - 19) 2019 Modelled IHME
14 (9 - 19) 2018 Modelled IHME
14 (9 - 19) 2017 Modelled IHME
13 (9 - 19) 2016 Modelled IHME
13 (9 - 19) 2015 Modelled IHME
13 (9 - 19) 2014 Modelled IHME
13 (9 - 19) 2013 Modelled IHME
13 (9 - 19) 2012 Modelled IHME
14 (9 - 19) 2011 Modelled IHME
14 (9 - 19) 2010 Modelled IHME
14 (9 - 19) 2009 Modelled IHME
14 (9 - 19) 2008 Modelled IHME
14 (9 - 19) 2007 Modelled IHME
14 (10 - 20) 2006 Modelled IHME
15 (10 - 20) 2005 Modelled IHME
15 (10 - 21) 2004 Modelled IHME
15 (10 - 21) 2003 Modelled IHME
15 (10 - 21) 2002 Modelled IHME
15 (10 - 21) 2001 Modelled IHME
15 (10 - 21) 2000 Modelled IHME
15 (10 - 21) 1999 Modelled IHME
15 (10 - 21) 1998 Modelled IHME
15 (10 - 21) 1997 Modelled IHME
16 (10 - 22) 1996 Modelled IHME
16 (10 - 22) 1995 Modelled IHME
16 (10 - 22) 1994 Modelled IHME
16 (10 - 22) 1993 Modelled IHME
16 (11 - 22) 1992 Modelled IHME
16 (10 - 22) 1991 Modelled IHME
16 (10 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
736
2019
(458 - 1,086)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
967
2019
(587 - 1,451)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines